The intracellular delivery of SCB4380 by liposome carriers inhibited cellular PTPRZ activity, and thereby suppressed cell migration and proliferation in vitro as well as tumor growth in vivo in rat C6 glioblastoma cells. Here, PTPRZ1 is linked to neoplasm.